FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154801101> ?p ?o ?g. }

• W2154801101 endingPage "366" @default.
• W2154801101 startingPage "356" @default.
• W2154801101 abstract "The aim of this study was to describe recovery of urinary continence and potency and report oncological and functional outcomes using the survival, continence and potency (SCP) system for patients undergoing robot-assisted radical prostatectomy (RARP).From 2009 to 2012, 232 patients underwent RARP. Self-reported continence, erection sufficient for intercourse (ESI) and scores on the five-item version of the International Index of Erectile Function-5 (IIEF-5) were registered by questionnaire and physician's interview preoperatively and at 3, 6 and 12 month follow-up, and subsequently on a yearly basis. Continence was defined as 0 pads, and potency as ESI or IIEF-5 greater than 17 with or without the aid of phosphodiesterase type 5 inhibitors. Oncological success was defined as absence of biochemical failure (BF) [prostate-specific antigen (PSA) ≥ 0.2 ng/ml]. The SCP system was used to evaluate combined oncological and functional outcomes.In total, 184 patients were followed for more than 1 year. The 12 month BF-free survival rate was 97.7%. Median time to regain continence was 6.2 months; 12 months postoperatively 79.9% used 0 pads/day. Of patients with preoperative ESI, 77.6% (67.9-86.1) and 34.4% (24.1-47.5) maintained ESI 12 months postoperatively after bilateral and unilateral nerve-sparing surgery (NS), respectively. NS (p < 0.0001), increasing prostate volume (p = 0.014) and lower age (p < 0.0001) were positively associated with recovery of potency. Using the SCP system and defining potency as ESI, functional and oncological success 12 months after surgery was achieved in 69 out of 135 (51.1%) preoperative continent and potent patients who underwent unilateral or bilateral NS, and did not require adjuvant treatment; when defining potency as IIEF greater than 17, this figure was 45 out of 108 (41.7%). As expected, the proportions were significantly higher for bilateral than for unilateral NS (p ≤ 0.0014).RARP provides good early BF-free survival, continence and potency recovery rates for patients eligible for NS." @default.
• W2154801101 created "2016-06-24" @default.
• W2154801101 creator A5015989482 @default.
• W2154801101 creator A5021905609 @default.
• W2154801101 creator A5026992815 @default.
• W2154801101 creator A5028709604 @default.
• W2154801101 creator A5063977962 @default.
• W2154801101 date "2014-03-03" @default.
• W2154801101 modified "2023-10-16" @default.
• W2154801101 title "Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy" @default.
• W2154801101 cites W1547280737 @default.
• W2154801101 cites W1963896164 @default.
• W2154801101 cites W1982332031 @default.
• W2154801101 cites W1989073697 @default.
• W2154801101 cites W2002114455 @default.
• W2154801101 cites W2009346005 @default.
• W2154801101 cites W2024983375 @default.
• W2154801101 cites W2026641917 @default.
• W2154801101 cites W2029620617 @default.
• W2154801101 cites W2054450921 @default.
• W2154801101 cites W2058519695 @default.
• W2154801101 cites W2059706709 @default.
• W2154801101 cites W2064143632 @default.
• W2154801101 cites W2071163364 @default.
• W2154801101 cites W2090434840 @default.
• W2154801101 cites W2091333929 @default.
• W2154801101 cites W2104976986 @default.
• W2154801101 cites W2124301825 @default.
• W2154801101 cites W2132749577 @default.
• W2154801101 cites W2137371729 @default.
• W2154801101 cites W2144322007 @default.
• W2154801101 cites W2146598700 @default.
• W2154801101 cites W2154175918 @default.
• W2154801101 cites W2157123352 @default.
• W2154801101 cites W2157804517 @default.
• W2154801101 cites W2169789386 @default.
• W2154801101 doi "https://doi.org/10.3109/21681805.2014.893534" @default.
• W2154801101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24579803" @default.
• W2154801101 hasPublicationYear "2014" @default.
• W2154801101 type Work @default.
• W2154801101 sameAs 2154801101 @default.
• W2154801101 citedByCount "5" @default.
• W2154801101 countsByYear W21548011012016 @default.
• W2154801101 countsByYear W21548011012017 @default.
• W2154801101 countsByYear W21548011012019 @default.
• W2154801101 crossrefType "journal-article" @default.
• W2154801101 hasAuthorship W2154801101A5015989482 @default.
• W2154801101 hasAuthorship W2154801101A5021905609 @default.
• W2154801101 hasAuthorship W2154801101A5026992815 @default.
• W2154801101 hasAuthorship W2154801101A5028709604 @default.
• W2154801101 hasAuthorship W2154801101A5063977962 @default.
• W2154801101 hasConcept C121608353 @default.
• W2154801101 hasConcept C126322002 @default.
• W2154801101 hasConcept C126894567 @default.
• W2154801101 hasConcept C141071460 @default.
• W2154801101 hasConcept C185592680 @default.
• W2154801101 hasConcept C202751555 @default.
• W2154801101 hasConcept C2776235491 @default.
• W2154801101 hasConcept C2776547966 @default.
• W2154801101 hasConcept C2777008409 @default.
• W2154801101 hasConcept C2778531004 @default.
• W2154801101 hasConcept C2779466945 @default.
• W2154801101 hasConcept C2779478474 @default.
• W2154801101 hasConcept C2779819210 @default.
• W2154801101 hasConcept C2779929075 @default.
• W2154801101 hasConcept C2993211783 @default.
• W2154801101 hasConcept C3020768380 @default.
• W2154801101 hasConcept C55493867 @default.
• W2154801101 hasConcept C57992300 @default.
• W2154801101 hasConcept C71924100 @default.
• W2154801101 hasConceptScore W2154801101C121608353 @default.
• W2154801101 hasConceptScore W2154801101C126322002 @default.
• W2154801101 hasConceptScore W2154801101C126894567 @default.
• W2154801101 hasConceptScore W2154801101C141071460 @default.
• W2154801101 hasConceptScore W2154801101C185592680 @default.
• W2154801101 hasConceptScore W2154801101C202751555 @default.
• W2154801101 hasConceptScore W2154801101C2776235491 @default.
• W2154801101 hasConceptScore W2154801101C2776547966 @default.
• W2154801101 hasConceptScore W2154801101C2777008409 @default.
• W2154801101 hasConceptScore W2154801101C2778531004 @default.
• W2154801101 hasConceptScore W2154801101C2779466945 @default.
• W2154801101 hasConceptScore W2154801101C2779478474 @default.
• W2154801101 hasConceptScore W2154801101C2779819210 @default.
• W2154801101 hasConceptScore W2154801101C2779929075 @default.
• W2154801101 hasConceptScore W2154801101C2993211783 @default.
• W2154801101 hasConceptScore W2154801101C3020768380 @default.
• W2154801101 hasConceptScore W2154801101C55493867 @default.
• W2154801101 hasConceptScore W2154801101C57992300 @default.
• W2154801101 hasConceptScore W2154801101C71924100 @default.
• W2154801101 hasIssue "4" @default.
• W2154801101 hasLocation W21548011011 @default.
• W2154801101 hasLocation W21548011012 @default.
• W2154801101 hasOpenAccess W2154801101 @default.
• W2154801101 hasPrimaryLocation W21548011011 @default.
• W2154801101 hasRelatedWork W1999936870 @default.
• W2154801101 hasRelatedWork W2154801101 @default.
• W2154801101 hasRelatedWork W2530461552 @default.
• W2154801101 hasRelatedWork W2535128797 @default.

• next